Desmopressin acetate use in von Willebrand’s disease: a survey on current practices in Brazil
Introduction: von Willebrand’s disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemen...
Main Authors: | Maria Sueli da Silva Namen Lopes, Suely Meireles Rezende |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920300067 |
Similar Items
-
Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01) -
Desmopressin for reducing perioperative blood transfusion
by: Brit Long, et al.
Published: (2021-04-01) -
Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives
by: Castaman G, et al.
Published: (2021-03-01) -
Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
by: Mouhamed Yazan Abou‐Ismail, et al.
Published: (2021-02-01) -
VON WILLEBRAND DISEASE: DIAGNOSIS AND TREATMENT
by: Majda Benedik Dolničar
Published: (2004-12-01)